Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM" with the PARTICIPATION of PATIENTS with DYSBIOSIS (phase 2)

NCT06886399 is registered in ClinicalTrials.gov with Industrial Microbiology LLP as lead sponsor.

NCT NCT06886399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06886399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM" with the PARTICIPATION of PATIENTS with DYSBIOSIS (phase 2)
Lead sponsor
Industrial Microbiology LLP
Phase
Phase 2
Overall status
Completed
Start date
July 22, 2024
Completion date
August 11, 2024
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysbacteriosis, intestinal infections